Kunping Ju
Jinan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
An exploration of the effectiveness and safety of 7‑day triple therapy with amoxicillin and tetracycline for Helicobacter pylori eradication: A propensity score matching analysis.
Journal: International journal of antimicrobial agents
Published: March 31, 2026
Comparator Choice in Helicobacter pylori Eradication: Tegoprazan-Amoxicillin Dual Therapy Versus an Optimized Bismuth-Containing Quadruple Therapy in a Randomized Trial and Meta-Analysis.
Journal: International journal of antimicrobial agents
Published: March 30, 2026
Vonoprazan-Based Dual and Quadruple Therapy with Varying Duration for Helicobacter pylori Eradication: A Multicenter, Randomized Controlled Trial.
Journal: International journal of antimicrobial agents
Published: March 11, 2026
Comparative Analysis of High-Dose Dual Therapies in First-Line Helicobacter pylori Eradication: An Inverse Probability of Treatment-Weighted Multicenter Study.
Journal: The Journal of infectious diseases
Published: November 26, 2025
De Novo Multi-Mechanism Antimicrobial Peptide Design via Multimodal Deep Learning.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 18, 2025
Amoxicillin or tetracycline in bismuth-containing quadruple therapy for Helicobacter pylori eradication: a systematic review and meta-analysis.
Journal: Frontiers in microbiology
Published: July 17, 2025
Optimizing Helicobacter pylori Eradication Therapies: From Trial to Real World.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: March 12, 2024
Showing 1-8 of 8
Last Updated: 09/26/2026